UNH
UnitedHealth Group Inc.
Price History
Why Is UNH ▼ Down Today?
-1.51%
Full AI analysis generates after market close. Showing live price data.
Financial Highlights
Income Statement
Balance Sheet
Cash Flow
Highly Regarded Analysis
Executive Summary
UnitedHealth Group Incorporated (UNH) is a diversified healthcare company that provides health coverage, software, and data consultancy services through its UnitedHealthcare and Optum segments. The company recently reported strong third-quarter 2026 results, exceeding earnings and revenue estimates and subsequently raising its full-year 2026 guidance. With a significant market capitalization, UNH is a major player in the managed-care organization market, demonstrating strong operational efficiency and a diversified business model that includes health plans, pharmacy care services, and health technology solutions.
Bull Case
The bull case for UNH is supported by its continued strong execution across its highly diversified Optum platform (Optum Health, Optum Insight, Optum Rx) and the UnitedHealthcare segment. Effective management of regulatory challenges and sustained strong earnings growth, particularly in areas like Medicare Advantage and data analytics, could drive the stock higher. The company's significant scale, diversified operations, and ongoing investments in innovation are expected to support margin recovery and consistent earnings expansion.
Bear Case
The bear case for UNH primarily revolves around increased regulatory scrutiny, especially regarding vertical integration and pharmacy benefit management (PBM) practices, which could lead to divestitures or operational limitations. There's also a risk of Medicare Advantage margin collapse due to rising medical costs and changes in risk adjustment methodologies. Furthermore, the compounding financial impact from cyberattacks, such as the Change Healthcare incident, and intense competition could negatively affect the stock's performance. The stock has historically been susceptible to steep declines during market downturns.
Technical Outlook
UNH is currently trading near the top of its 52-week range and above its 200-day simple moving average. The stock price has shown a significant increase over the past year, rising by 17.56% over the last year and 1.95% in the past 24 hours to $421.80. Historically, the stock has experienced considerable volatility, including a sharp decline in April 2025.
Fundamental Health
UnitedHealth Group exhibits strong fundamental health. For Q3 2026, the company reported consolidated revenues of $112.7 billion and adjusted earnings of $4.69 per share, surpassing analyst estimates. The full-year 2026 adjusted net earnings outlook has been raised to at least $20.50 per share. Operational efficiency has improved, with the medical care ratio improving to 88.4%. The company has demonstrated a decent 10% annualized revenue growth over the last five years and is targeting a long-term debt-to-capital ratio of approximately 40.0% by year-end 2026.
Key Catalysts
- Regulatory developments related to vertical integration and PBMs.
- Trends in Medicare Advantage enrollment and medical loss ratios.
- Performance and expansion of the Optum segments (Health, Insight, Rx).
- Resolution and financial impact of the Change Healthcare cyberattack.
- Future earnings reports and updated financial guidance.
Sources
This analysis is AI-assisted and reviewed by our editorial team. It is not financial advice. Always do your own research and consult a financial advisor before making investment decisions.
Go Deeper on UNH
Key Stats
Next Earnings
UNH News
No recent news for UNH.
